High-dosage fosfomycin results in adequate plasma and target-site exposure in morbidly obese and nonobese nonhyperfiltration patients - Busse, D; Simon, P; Petroff, D; El-Najjar, N; Schmitt, L; Bindellini, D; Dietrich, A; Zeitlinger, M; Huisinga, W; Michelet, R; Wrigge, H; Kloft, C (Antimicrob Agents Chemother, 2022)